chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately had major pain and burning at immunization site. Nurse said it would subside. Got home and couldn't move arm without excrutiating pain. Arm had swollen to three X its normal size. It was red, had fever in it and streaking. If I walked or moved it I would scream out with pain. Called physicians ofc and was told to use ice. Have photos I took during the 7 days of the above. I am now seeing a PT due to the above problems. During this period, I have had weakness, and spent days in bed due to the pain. I have not regained full use of this arm and pain is still there. The strength I had in this arm is so weak that I cannot lift my purse, vacuum floors or do anything that requires any physical work fully without pain.
About 2 weeks, post vax, child developed bright red bleeding upper gums, fever, irritability, total loss of appetite. This lasted for 3 weeks. Child was taken to doctor on 8/12/98. He had a primary herpes outbreak. All symptoms lead to the first initial outbreak of oral herpes. Within 2-3 months, the child developed visible oral herpes. Will have oral herpes forever.
She stated she felt bad after the vaccine for a day; This is a spontaneous report from a non-contactable consumer (Patient herself) from a Pfizer-sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient stated she felt bad after the vaccine for a day. She didn't feel good for a day. The patient stated both patient and her husband got their 1st dose and were part of a recording thing and it would text them how they were feeling etc. Advised not sure what app or texting app they are using would need to reach out to health department. She thinks she hit stop because now they were getting nothing. Outcome of the event was recovered.  No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.
MOM NOTICED SWELLING IN THE ARM THAT VARICELLA VACCINE WAS GIVEN. THE SWELLING WAS THE SIZE OF A DONUT WITH A QUARTER SIZED AREA WHITHIN THE SWELLING THAT LOOKED "BLISTERY AND BUBBLY". MOM TOOK PATIENT TO ER FRIDAY MORNING ON 4/19/2013. ER PHYSICIAN SAID TO GIVE MOTRIN AND TO APPLY HEAT TO THE AREA.
Mom states patient received 5TH DTAP on Friday on right leg and had fever of 106.0 and was crying a lot. Mom states she gave patient motrin and has done cold patches. Mom states he has a big lump, the site is really hot and he does not want to eat. Mom states he had fever yesterday still and right now its 99.0. She states he is able to walk normal but complains of pain on and off. Mom sent pictures of leg. Mom seems upset with vaccines and states repeatedly that she wants to talk to Dr. She states a lump and heat is not normal. Discussed patient symptoms with provider. RN advised mom to take patient to an urgent care due to lump size and no appointments available. Dr. to send over recommendations and will send to patient through system. Scheduled patient an appointment for Thursday to discuss vaccines. Told mom to call back for any worsening symptoms. Provided mom with VAERS phone number and will complete safe link.  Mom states she will go to an Urgent care and verbalized understanding.
The night after I received the Johnson and Johnson vaccine I had 101.7 fever, chills, shaking. The next two days my hands got really dry and the skin peeled off them. 3 days later I fainted.
Patient, age 32, is seen today in regards to (R) arm cellulitis. By patient report, he was seen on 11/07/2014, U.C. after a long absence (previously followed by dr, no maintenance medication in two years). He has abdominal pain and diarrhea, typically having 2-4 bowel movements daily, usually diarrhea with visible mucus, no blood. He was prescribed both UCERIS and LIALDA, both of which were started yesterday. He received both influenza and pneumonia vaccines on 11/07/2014 and has had erythematous, warm skin (R) upper arm, injection site. he is taking oral KEFLEX; however, redness has worsened. He had a fever; however, claims fever since resolved.
Initial report was received from a health care professional on 15 September 2011. A 69 year-old female with no reported past medical history had received on 17 August 2011 at "2", an intramuscular left arm FLUZONE HIGH-DOSE No Preservative 2011-2012, lot number UH436AC. On 19 August 2011 in the AM, the patient experienced cough, general malaise for two weeks, nasal drip, excessive phlegm and a sensation of choking. The cough and malaise "cleared up" (date not reported). Adverse events following prior vaccination, illness at the time of vaccination and any other vaccines within four weeks prior to the suspect vaccine were all reported as "none". No further information was available at the time of the report. The patient was not recovered at the time of report. According to the reporter, outcome was unknown. Follow-up information was received from a healthcare professional on 26 October 2011. From new information received, it was determined this case now meet seriousness criteria, and it has been upgraded from non-serious to serious. The patient was seen by her primary care physician for follow-up and was diagnosed with pneumonia. The patient received corrective treatment with antibiotic (drug unknown) and is feeling fine. The patient outcome was reported as recovered/resolved. Documents held by sender: none.
This spontaneous report concerning a 61 years old female patient was received from the patient herself. No concurrent conditions were reported. The patient's medical history included a cystometrogram about 10 years ago. The patient had no drug reaction or allergies. On an unknown date in 2015 (reported as "a year ago"), the patient was vaccinated with ZOSTAVAX (strength, dose, frequency, lot and expiration date were not provided) by "injection" route. Concomitant therapies included an unspecified thyroid medication, WELLBUTRIN and VALIUM. On 03-JUN-2016, the patient experienced shingles (herpes zoster). In addition, on an unknown date in June 2016, she had an outpatient visit to the Hospital because the event became more severe on an unspecified date. The patient was prescribed with hydrocodone by the attending physician. No laboratory diagnostic studies were performed. No product quality complain was involved. At the time of reporting, the outcome of the event of herpes zoster was reported as not recovered. The causality between the event of herpes zoster and ZOSTAVAX was not assessed. Additional information has been requested.
Systemic: Fainting / Unresponsive-Medium, Systemic: Hypertension-Severe, Additional Details: patient received second dose of covid vaccine between 1-2 pm, waited in observation area for 15 minutes, returned to work about an hour later (on-site), entered into a room and immediately fainted hitting head.  BP was checked and it was 189/100.  EMS was called, patient went in to be checked out.  When ending the on-site clinic at facility, we had not received any information from the patient.  Healthcare person listed is the administrator of the facility.
Pt got vaccine on 9/11/17 in left deltoid. She called today (9/14/17) and reported she has redness, swelling, itching, warmth on the same arm as of 9/13/17. I directed her to see her MD and opened a claim with our company.
feeling more tired; red, itchy spot that showed up on the injection site; red, itchy spot that showed up on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red, itchy spot that showed up on the injection site), VACCINATION SITE ERYTHEMA (red, itchy spot that showed up on the injection site) and FATIGUE (feeling more tired) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL, VITAMIN C [ASCORBIC ACID] and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (red, itchy spot that showed up on the injection site) and VACCINATION SITE ERYTHEMA (red, itchy spot that showed up on the injection site). On 16-Feb-2021, the patient experienced FATIGUE (feeling more tired). On 17-Feb-2021, FATIGUE (feeling more tired) had resolved. At the time of the report, VACCINATION SITE PRURITUS (red, itchy spot that showed up on the injection site) and VACCINATION SITE ERYTHEMA (red, itchy spot that showed up on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 17-Feb-2021, the patient developed pink spot (2- 3 inches in diameter) south of the injection site. Other concomitant medications included flanconade and multivitamin centrum. Treatment information was not reported.
his hand is numb; can't make a fist; This spontaneous case was reported by a pharmacist and describes the occurrence of HYPOAESTHESIA (his hand is numb) and HYPOAESTHESIA (can't make a fist) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No medical history was reported by the patient.     On 16-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jun-2021, the patient experienced HYPOAESTHESIA (his hand is numb) and HYPOAESTHESIA (can't make a fist). On 16-Jun-2021, HYPOAESTHESIA (his hand is numb) and HYPOAESTHESIA (can't make a fist) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Concomitant medication was not provided.  No treatment medication was reported.
pt taken to MD on 17APR96 d/t hives on skin & joint pain starting about 1wk p/vax; became worse when exposed to heat;given serovent PCN for wheezing & claritin;CBC & lytes nl;apt 3MAY96 w/MD;dx serum sickness from MMR:joint weak;
sore throat started at 4:00 pm, followed by severe chills and fever of over 101. Fever lasted for 24 hours. Muscle aches, extreme tiredness lasted for 5 days. spotting of period began 72 hours after vaccine and lasted 5 days. I have an iud and don?t typically spot or have menstrual flow.
Patient was given 0.3 mL instead of 0.25 mL of Moderna Booster Vaccine.
About 4 days after receiving his vaccine he began to have difficulty with chewing, swallowing and speaking.  He describes waking up in the morning with paresthesias of numbness from the nose down to his jaw.  He is scared to eat due to fear of choking.  He notes as he continues to chew or speak he gets fatigued.  He denies any difficulty with breathing or generalized weakness.  He does report coughing with secretions.  He reports his symptoms have been ongoing for 2 weeks with no improvement.  Patient ended up getting admitted to the hospital for IVIG treatment for the myasthenia gravis flare.
Mom called Thursday am, stating daughter's left arm red and swollen.  Mom had not put ice to it Wednesday as instructed.  Encouraged Mom to give Tylenol and put warm compress Thursday if no better to call Friday.  Called Friday am left arm still red, swollen, and feverish.  Told Mom to take child to pediatrician today.  Was seen by pediatrician on 06/10/2005 Benadryl recommended and patient has recovered.
Lower back pain while sleeping. Neck pain started on 9/21. Joint pain started 9/23. The neck pain & stiffness has been so severe I was unable to turn my neck by 10/3. Currently experiencing fatigue, joint pain, neck pain & severe stiffness, sweating (no fever) through 10/9/15.
This spontaneous report as received from a pharmacist refers to 2 patients who were vaccinated with lot # (669579/0595AA) PNEUMOVAX23 on 19-SEP-2012 (expired date: 31-AUG-2012). On 19-SEP-2012 the expired lot of vaccine was inadvertently administered. The same lot was also administered on 14-SEP-2012 and on 18-SEP-2012. The pharmacist wanted to know if this dose was valid or if these patients needed to be revaccinated. The outcome for the event was unknown. Additional information has been requested.
Looks brusied, purple in color; Hard spot area in her right arm is approximately 4" across; Left hand was stiff; Left hand swollen; Left hand hurt; Right arm started to swell up; Right arm hot; Covid arm; Feeling tired; Red spot at injection site/vaccinateion site turned red almost immediately; Hurt when vaccine was injected /right arm was tender; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Right arm started to swell up), FEELING HOT (Right arm hot), VACCINATION SITE REACTION (Covid arm), PERIPHERAL SWELLING (Left hand swollen) and PAIN IN EXTREMITY (Left hand hurt) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 025J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy, Drug allergy (Codeine), Sulfonamide allergy, Iodine allergy and Sun sensitivity (Causes eczema). Concomitant products included VITAMINS NOS for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Hurt when vaccine was injected /right arm was tender). On 20-Feb-2021, the patient experienced PERIPHERAL SWELLING (Right arm started to swell up), FEELING HOT (Right arm hot), VACCINATION SITE REACTION (Covid arm), FATIGUE (Feeling tired) and VACCINATION SITE ERYTHEMA (Red spot at injection site/vaccinateion site turned red almost immediately). On 22-Feb-2021, the patient experienced PERIPHERAL SWELLING (Left hand swollen). 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (Left hand hurt). On 23-Feb-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Left hand was stiff). On 03-Mar-2021, the patient experienced CONTUSION (Looks brusied, purple in color) and VACCINATION SITE INDURATION (Hard spot area in her right arm is approximately 4" across). The patient was treated with Physical therapy (Cold compress) for Vaccination site reaction. At the time of the report, PERIPHERAL SWELLING (Right arm started to swell up), FEELING HOT (Right arm hot), VACCINATION SITE REACTION (Covid arm), PERIPHERAL SWELLING (Left hand swollen), PAIN IN EXTREMITY (Left hand hurt), MUSCULOSKELETAL STIFFNESS (Left hand was stiff), CONTUSION (Looks brusied, purple in color), VACCINATION SITE INDURATION (Hard spot area in her right arm is approximately 4" across), FATIGUE (Feeling tired), VACCINATION SITE PAIN (Hurt when vaccine was injected /right arm was tender) and VACCINATION SITE ERYTHEMA (Red spot at injection site/vaccinateion site turned red almost immediately) outcome was unknown.            Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    This case was linked to mod-2021-035102 (Patient Link).
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Sep2021 as dose 3 (booster), single (Lot number: PF8839), in left arm and on 02May2022 as dose 4 (booster), single (Lot number: FJ4991) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. No known allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 including received Paxlovid from 03Aug2022 to 07Aug2022.
Patient had a giant red raised circle around where the injection was given it was warm to the touch and painful and itchy (felt like a burn) for the patient. She applied some hydrocortisone cream and took some Tylenol . She said it was on its way to recovery.
While waiting in room patient began to report that she was having some itching to her throat and her body. BENADRYL provided with positive effect patient stayed in clinic and V/S rechecked 97.2 B/P 126/76 HR 70 RR 16 Spo2 100% on RA patient denied any more itching at this time. Patient instructed to seek medical attention if any further issues arise, patient verbalized understanding.
patient had syncope reaction (turned pale, sweating, vision went black) for about 5 minutes. Patient did not lose consciousness
Low grade fever, body aches, headache to start. Fever continued to rise to 103.2F despite the use of acetaminophen and ibuprofen. Uncontrollably shaking with worsening body aches continued into the night.  Fever broke at aprox 0300 on 1/21/21. Following day began to feel better. Overall symptoms lasted approximately 16 hours.
Myalgia, Arthralgia, Fever, Diarrhea, NauseaVomiting, chills
It started off with a dry cough, sore muscles, headache, tiredness and slight fever 99.0. I took at home COVID-19 test on 03/16/2023. I then had a telehealth visit with my provider and was prescribed Paxlovid for 5 days. My symptoms were more severe on 03/16/2023 and 03/17/2023 with cough, fatigue, and pain. Also wanted to note with Paxlovid, it left a bad taste in my mouth. I will be taking another at home COVID-19 test tomorrow on 03/25/2023.
Nose started to feel weird; Nosebleed; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL DISCOMFORT (Nose started to feel weird), EPISTAXIS (Nosebleed) and HEADACHE (Headache) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025L20A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Jan-2021, the patient experienced NASAL DISCOMFORT (Nose started to feel weird), EPISTAXIS (Nosebleed) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) on 04-Jan-2021 for Headache, at an unspecified dose and frequency. On 04-Jan-2021, NASAL DISCOMFORT (Nose started to feel weird) and EPISTAXIS (Nosebleed) had resolved. On 06-Jan-2021, HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications provided.  After the first shot of moderna covid-19 vaccine he suffered a nose bleed 30-45minutes after receiving the shot. He then had a headache that evening.  Treatment information was not provided.   This case was linked to MOD-2021-033454 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: follow up received: reporter address was updated, dosing details were updated, race and ethicity was updated, narrative information was updated; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Left outer aspect of arm swollen with about 50mm by 50mm of protrusion.
Sycopal episode. BP 110/60 pulse 59 Resp 16.
States got flu shot 10/31/07 - States he showered but did not remove bandaid until next morning - then noticed red "itchy" bumpy area. States area around shot was also swollen. The red bumpy area on 11/05/07 was in area of padded part of bandaid - States he has latex allergy but bandaids weren't latex ones. 11-7-07 called him - States it is better he did stop by Dr's office on 11-5-07
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported. No adverse reactions were reported by patient.
Drug ineffective; Breakthrough COVID illness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 22 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 02Jan2022, outcome "not recovered", described as "Drug ineffective"; COVID-19 (medically significant) with onset 02Jan2022, outcome "not recovered", described as "Breakthrough COVID illness". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (30Dec2021) positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19. The patient did not take other vaccine in four weeks. Patient had no covid prior vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Tachycardic and hypertensive. Give 1 dose of Benadryl. Condition improved.